Ceapro Inc - Company Profile

Powered by

All the sales intelligence you need on Ceapro Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Ceapro Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Ceapro Inc.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Ceapro Inc (Ceapro) is a biotechnology company that focuses on the development and commercialization of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are used in nutraceutical, cosmeceutical, and therapeutics products for personal, cosmetics, humans, and animals. Ceapro’s natural active ingredients include avenanthramides, oat beta glucan, oat oil, oat peptides, oat powder and lupin peptides; natural anti-aging skincare products, and veterinary products include ear cleanse, oat shampoo and dermal complex/conditioner. The company uses its proprietary Pressurized Gas eXpanded (PGX) technology for extraction of active ingredients. It markets its products through distribution partners, subsidiaries and directly to final consumers. The company offers products in Canada, the US, China, Germany, Japan, Europe, India, and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.

Gain a 360-degree view of Ceapro Inc and make more informed decisions for your business Gain a 360-degree view of Ceapro Inc and make more informed decisions for your business Learn more
Headquarters Canada

Address 7824 51 Ave Nw, Edmonton, Alberta, T6E6W2


Telephone 1 780 4214555

No of Employees 12

Industry Pharmaceuticals and Healthcare

Revenue (2023) $7.1M

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Ceapro Inc premium industry data and analytics

7

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Ceapro Inc’s relevant decision makers and contact details.

6

Clinical Trials

Determine Ceapro Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

3

Catalyst Calendar

Proactively evaluate Ceapro Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Pipeline Drugs

Identify which of Ceapro Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

Products and Services

Products Services
Natural Anti-Aging Skincare Contract Manufacturing Services
Beta Glucan
Avenanthramides
XYZ
XYZ
XYZ
Understand Ceapro Inc portfolio and identify potential areas for collaboration Understand Ceapro Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Ceapro Inc Medicamen Biotech Ltd Microbix Biosystems Inc Aptose Biosciences Inc Eurofins Alphora
Headquarters Canada India Canada Canada Canada
City Edmonton New Delhi Mississauga Toronto Mississauga
State/Province Alberta Delhi Ontario Ontario Ontario
No. of Employees 12 378 69 35 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Ronnie Miller Chairman Executive Board - -
Gilles R. Gagnon President; Chief Executive Officer; Director Executive Board - -
Stacy Prefontaine Chief Financial Officer Senior Management - -
Sigrun Watson Chief Revenue Officer Senior Management 2022 -
Denis Bilodeau Strategic Advisor Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Ceapro Inc key executives to enhance your sales strategy Gain insight into Ceapro Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?